Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Adma Biologics (ADMA) Receivables - Other (2016 - 2018)

Adma Biologics' Receivables - Other history spans 3 years, with the latest figure at $961145.0 for Q4 2018.

  • For Q4 2018, Receivables - Other fell 22.84% year-over-year to $961145.0; the TTM value through Dec 2018 reached $961145.0, down 22.84%, while the annual FY2018 figure was $961145.0, 22.84% down from the prior year.
  • Receivables - Other reached $961145.0 in Q4 2018 per ADMA's latest filing, down from $1.0 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $1.2 million in Q4 2017 to a low of $726409.0 in Q1 2018.
  • Average Receivables - Other over 3 years is $1.0 million, with a median of $987823.0 recorded in 2016.
  • Peak YoY movement for Receivables - Other: increased 28.46% in 2017, then dropped 22.84% in 2018.
  • A 3-year view of Receivables - Other shows it stood at $969675.0 in 2016, then rose by 28.46% to $1.2 million in 2017, then decreased by 22.84% to $961145.0 in 2018.
  • Per Business Quant, the three most recent readings for ADMA's Receivables - Other are $961145.0 (Q4 2018), $1.0 million (Q3 2018), and $1.0 million (Q2 2018).